The largest database of trusted experimental protocols

Minimax300

Manufactured by Molecular Devices
Sourced in United States

The MiniMax300 is a compact and versatile lab equipment designed for a range of applications. It features a high-resolution detector and advanced optics to provide accurate and reliable data. The device's core function is to perform precise measurements and analysis, making it a valuable tool for researchers and scientists.

Automatically generated - may contain errors

4 protocols using minimax300

1

Quantifying Aortic Fibroblast Adherence

Check if the same lab product or an alternative is used in the 5 most similar protocols
Six thousand control or TAA aortic fibroblasts were added to the wells of black wall, clear bottom 96‐well plates (3631; Corning). Duplicate plates were prepared (washed and unwashed) for comparative analysis to account for minor variations in cell count. All plates were incubated at 37°C for exactly 1 hour to allow for adherence. One of the duplicate plates was washed with PBS 5 times using an automated plate washer (Aquamax 200 with cell wash head; Molecular Devices, Sunnyvale, CA), and both plates were then incubated with Cyquant (C7026; Thermo Fisher Scientific) for 1 hour. Nuclei of adhered fibroblasts were counted on the Spectramax i3x with the MiniMax300 imaging cytometer (Molecular Devices). Each cell line was an average count of 8 replicate wells. Washed plates were compared with unwashed plates, and the difference was represented as fold change from unwashed.
+ Open protocol
+ Expand
2

Quantification of NF-κB and AP-1 Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
NF-κB activation was quantified by measuring gaussia luciferase (Gluc) reporter using the Secrete-PairTM Gaussia Luciferase Dual Luminescence Assay Kit (THP, Vienna, Austria; LF062) according to the manufacturer’s instructions. AP-1 activation was determined by measuring firefly luciferase (Fluc) reporter using the Luc-PairTM Firefly Luciferase HT Assay Kit (THP, Vienna, Austria; LF018) according to the manufacturer’s instructions. Relative luminescence units (RLU) were measured in a plate reader (SpectraMaxi3x, Molecular Devices, LLC, San Jose, CA, USA; Luminescence Glow, Lum 384 cartridge), and normalized to the cell count generated with an imaging cytometer (Mini Max 300, Molecular Devices, LLC, San Jose, CA, USA).
+ Open protocol
+ Expand
3

Measurement of Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The relative cell proliferation rate was determined using two different methods, as follows. (1) The fluorescence intensity of turboGFP was measured over 96 h in replicates (n = 12), using the Spectramax i3x microplate reader (Molecular Devices, San Jose, CA, USA) with the Minimax 300 imaging cytometer with a wavelength 456 for excitation and 541 for emission. The relative increase in turboGFP was compared to the intensity at the first measurement (at ~15–18 h). (2) Metabolically active cells were analyzed with the CellTiter-Glo™ Luminescent Cell Viability Assay (Promega Corp., Madison, WI, USA), according to the manufacturer’s instructions. Cells were cultured in replicates (n = 6), in opaque white 96-well plates, 1 × 104 and 1.5 × 103 cells/well for the 22Rv1 and PC-3 cell lines, respectively. After 72 h, the CellTiter-Glo™ reagent (Promega Corp.) was added and luminescence was determined on the Spectramax i3x (Molecular Devices) microplate reader.
+ Open protocol
+ Expand
4

Cytotoxicity Assessment of Plasma Supplementation

Check if the same lab product or an alternative is used in the 5 most similar protocols
StainFree™ cell detection technology was used to evaluate toxicity for plasma supplementation by cell confluence analysis. The imaging cytometry assay was performed using the SpectraMax i3 plate reader coupled to the MiniMax 300 imaging cytometer (Molecular Devices, USA) with the optical imaging module and transmitted light configuration. Briefly, 4 × 102 ADSC were seeded in 96-well plates, and treatment was started after 24 h. Confluence and proliferation data were recorded. Results were expressed as a percentage (%) of confluence along 18 consecutive days of treatments.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!